Competition between Delta and the Abruptex domain of Notch by Pei, Zifei & Baker, Nicholas E
BioMed  Central
Page 1 of 14
(page number not for citation purposes)
BMC Developmental Biology
Open Access Research article
Competition between Delta and the Abruptex domain of Notch
Zifei Pei and Nicholas E Baker*
Address: Department of Molecular Genetics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
Email: Zifei Pei - zpei@aecom.yu.edu; Nicholas E Baker* - nbaker@aecom.yu.edu
* Corresponding author    
Abstract
Background: Extracellular domains of the Notch family of signalling receptors contain many EGF
repeat domains, as do their major ligands. Some EGF repeats are modified by O-fucosylation, and
most have no identified role in ligand binding.
Results: Using a binding assay with purified proteins in vitro, it was determined that, in addition
to binding to Delta, the ligand binding region of Notch bound to EGF repeats 22–27 of Notch, but
not to other EGF repeat regions of Notch. EGF repeats 22–27 of Drosophila Notch overlap the
genetically-defined 'Abruptex' region, and competed with Delta for binding to proteins containing
the ligand-binding domain. Delta differed from the Abruptex domain in showing markedly enhanced
binding at acid pH. Both Delta and the Abruptex region are heavily modified by protein O-
fucosylation, but the split mutation of Drosophila Notch, which affects O-fucosylation of EGF repeat
14, did not affect binding of Notch to either Delta or the Abruptex region.
Conclusion: The Abruptex region may serve as a barrier to Notch activation by competing for
the ligand-binding domain of Notch.
Background
The Notch mutation in the fruit fly Drosophila was the first
mutation of embryonic development ever described.
Notch  mutant embryos die from neural hyperplasia
because Notch is a negative regulator of neurogenesis[1,2].
In mammals, Notch signaling is involved in a wide array
of other developmental processes including somitogene-
sis, angiogenesis, germ cell proliferation, immune devel-
opment, axonal pathfinding, proliferation, and intestinal
patterning [3-6]. Notch signaling probably contributes to
the development, homeostasis and pathology of most
organs [7].
Notch proteins are conserved cell surface receptors. Both
Drosophila Notch and human Notch1 have extracellular
domains containing 36 tandem EGF repeats, as well as
other sequences[8]. A ligand binding domain comprising
the two EGF repeats 11 and 12 has been defined using a
cell adhesion assay. In this assay, Drosophila cells trans-
fected to express Notch derivatives adhere to cells trans-
fected to express either of two similar transmembrane
ligands, Delta or Serrate, only if Notch EGF repeats 11–12
are present[9]. Genetic studies of Notch mutant flies con-
firm the importance of the EGF repeat 11–12 region in
vivo[10]. EGF repeats 11–12 are far distant from the S2
proteolytic cleavage site that is thought to be the ligand-
dependent step in Notch activation (Figure 1). The jux-
tamembrane S2 site is protected by a structure involving 3
Lin-12/N repeats that lie C-terminal to the EGF repeats
[11]. How ligand binding at EGF repeats 11–12 is com-
municated to these distant regions of N is not known.
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Proteins expressed in this study Figure 1
Proteins expressed in this study. The entire N ECD structure is shown at bottom, for comparison to the expressed pro-
teins arranged above. Rectangular blocks represent EGF repeats and shaded circles, predicted O-fucosylation. Delta contains 
two domains, NT and DSL, conserved amino-terminal to its 9 EGF repeats. EGF repeats 11–12 from Notch, constituting the 
Ligand-Binding domain, are checquered. All Notch EGF repeats are shaded, and EGF repeats 24–29, affected by Abruptex 
mutations, are shaded darkly. The Fc domain (striped) is carboxy-terminal in all cases. Similar proteins lacking the Fc domain 
were also expressed (not shown). The LIN-12/N repeats are  represented by three rhomboids, disulfide bonds linking the two 
Notch chains by a vertical line, the ligand-sensitive S2 site by an arrow, and the trans-membrane domain by a solid bar.
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Little is known about the contribution of most of the EGF
repeats to Notch function. The EGF repeat regions of
Notch are predicted to form several rod-like arrays due to
Ca-coordination by the inter-repeat linkers that precludes
flexibility between repeats, with occasional linkers that do
not bind Ca perhaps allowing localized flexibility[12].
The overall tertiary structure, and whether it involves
interactions between inflexible EGF repeat regions, is not
known.
Mutations affecting the Notch extracellular region point
to functional importance for many EGF repeats in addi-
tion to the minimal ligand binding domain[13,14]. Simi-
larities between Notch from Drosophila, humans, and
other species further suggests functional conservation of
EGF repeat regions. Some of these regions might interact
with other ligands, or affect receptor clustering [15-20]. It
has also been suggested that some EGF repeats might
interfere with ligand binding[21].
Many EGF repeats are the substrate of an enzyme, OFUT-
1, that that transfers fucose to Ser or Thr residues preceed-
ing the third Cys of EGF repeats. The C2X4–5(S/T)C3 con-
sensus is found on 23 of the 36 EGF repeats of N, and 7 of
the 9 EGF repeats of Dl[22]. In addition, the O-fucosyl-
transferase 1 enzyme acts independently of its catalytic
activity, as a chaperone or trafficking factor [23,24]. A spe-
cific mutant allele of Notch, called split, is caused by an
I578T substitution in EGF repeat 14 [25,13]. split results in
increased Notch activity in some tissues, and introduces a
site for O-fucosylation where one is normally lacking [26].
A specific allele of Dl that is a dominant suppressors of spl,
called Dlsup5, corresponds to the G305R substitution[27].
It has been suggested that this mutation might prevent or
reduce O-fucosylation of EGF repeat 3 on Thr306[27,28].
This suggested increased fucosylation of Notch on EGF
repeat 14 might be suppressed by reduced fucosylation of
repeat 3 of Delta. We noticed that O-fucosylation sites are
predicted on many EGF repeats of Delta, but few on EGF
repeats 11–20 of Drosophila Notch.
We wondered whether other EGF repeat protein regions
might share properties with Delta. Like Delta, many of
EGF repeats 22–30 from N bear O-fucosylation sites. This
'Abruptex' region of Notch is known for dominant muta-
tions that affect EGF repeats 24–29 and which activate
Notch signaling[13,25,29-32].
Here we used in vitro binding studies to detect specific
binding between the ligand-binding region of Drosophila
Notch and other EGF-repeat protein regions. Both Delta
and the Abruptex region of Notch showed high affinity
binding. We did not identify any effect of the split mutant,
but the studies suggest that the Abruptex domain could
oppose Notch activation by competing with Delta for the
ligand binding site.
Results
In vitro interaction between extracellular domains of 
Notch and Delta proteins from Drosophila
An in vitro binding assay was explored as a means to
detect interactions between EGF repeat regions of Notch
and its ligand Delta. Hirai's group found that purified
extracellular domains of mouse Notch2 and its ligand
Jagged2 could interact independently of the cell surface
when Notch2 extracellular-domains were adsorbed to an
ELISA plate, and Jagged2 extracellular domains expressed
as ligand-Fc fusion proteins[33]. The Fc domain from
human IgG dimerizes the ligand, also serves as an affinity
tag for purification, and is readily detected using second-
ary antibodies. The method is semi-quantitative and
unlike cell surface expression experiments is less affected
by variation in transgene expression level since the extra-
cellular domains are partially purified before use[33,34].
We tested whether similar methods could detect interac-
tion between Drosophila Notch and its ligand Delta. Dro-
sophila Schneider cells were transfected to express secreted
portions of the extracellular domains of Dl and Notch,
tagged with a His6 tag and, where appropriate, the Fc
domain from a human IgG (see Materials and Methods).
All proteins expressed and purified in the course of our
experiments are listed in Figure 1.
To test whether purified extracellular domains of Dl and
N from Drosophila could interact, we assessed the binding
of purified Dl:Fc fusion proteins to V5-tagged, His-tagged
EGF repeats 11–20 of the N extracellular domain. Hence-
forth we refer to this protein as N11-20. Figure 2 shows
binding data for the interaction between Dl:Fc and N11-
20 or N21-30. Fc-tagged proteins were detected using
HRP-conjugated anti-Fc antibodies and a colorimetric
assay.
Dl:Fc showed saturable binding to the N11-20 protein
that contained the known Dl-binding site at EGF repeats
11–12 (Figure 2A). Human IgG alone bound negligibly to
N11-20 (Figure 2B). Therefore, Dl sequences were respon-
sible for the binding by Dl:Fc. Specific binding depended
on the N11-20 protein, and was not evident when only
BSA carrier was bound to the plate (Figure 2C). Dl:Fc also
did not bind specifically to a N21-30 protein, which con-
tained the same number of EGF repeats as N11-20 but
lacked the known Dl-binding site (Figure 2D). Thus, in
this assay Dl:Fc bound a portion of Notch that contain the
Dl-binding site, and not to another EGF repeat portion of
Notch that lacked the ligand binding domain.BMC Developmental Biology 2008, 8:4 http://www.biomedcentral.com/1471-213X/8/4
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In the experiment shown in Figure 2, Dl:Fc binding was
half-maximal at 1.87 nM, compared to 0.7 nM measured
for Jagged:Fc binding Notch2 in similar experiments[33].
It should be noted that half-maximal binding data do not
correspond to true Kd values, because the stoichiometry
of binding is unknown and because these may not be
equilibrium binding measurements. In addition, whereas
measurements were so reproducible in the short term that
many error bars are invisibly small, they varied over
weeks, perhaps depending on purity and storage of pro-
tein preparations. Therefore, quantitative comparisons
have been made only between simultaneous, parallel
experiments.
In the experiment shown in Figure 2A, Dl:Fc binding to
200 ng N11-20 protein saturated at 2.407 × 10E-5 nmol
of Dl:Fc, 5.3% of the 4.56 pmoles of adsorbed N11-20.
The stoichiometry of Dl/N binding is not known, but
seems unlikely to be 1:20. More likely is that much of the
adsorbed Notch is not available for binding, a typical
finding when protein is adsorbed in non-oriented fash-
ion.
In all remaining experiments, specific binding data are
presented from which measured binding to BSA has been
subtracted, although such background binding was
always low.
EGF repeat O-fucosylation and its contribution to binding 
specificities
To assess the effect of the split mutation, N11-14 proteins
were prepared with either wild type sequences or contain-
Binding of Dl:Fc to a Notch protein including EGF repeats 11–12 Figure 2
Binding of Dl:Fc to a Notch protein including EGF repeats 11–12. A. Dl:Fc binding to adsorbed N11-20, measured 
using HRP-conjugated anti-human IgG. In these and all subsequent experiments, error bars are standard deviations of parallel 
replicate experiments. Note that binding is saturable and therefore likely to be specific. Saturation binding and "Kd" (half-maxi-
mal binding) were estimated by the Prizm software package. B. Human IgG bound negligibly to N11-20, indicating that Dl 
sequences were responsible for most binding seen in panel A. C. Dl:Fc did not bind adsorbed BSA, so most of the binding in 
panel A was to adsorbed N11-20:V5:His. In subsequent figures, non-specific BSA binding by Fc fusion proteins has been meas-
ured and subtracted, so that binding specific to adsorbed N proteins is presented. D. Dl:Fc did not bind specifically to N21-30, 
another EGF repeat protein of equal length to N11-20, but lacking the known ligand binding site. Note that the small amount 
of signal detected is mostly present in the absence of added Dl:Fc protein, is not saturable, and is therefore likely to be non-
specific.BMC Developmental Biology 2008, 8:4 http://www.biomedcentral.com/1471-213X/8/4
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ing the I578T change from the spl mutation that inserts an
O-fucosylation site on EGF repeat 14 (Figure 1). Previous
studies show that the T578 mutant is O-fucosylated in
Drosophila S2 cells [26]. Like N11-20, the N11-14 protein
was bound by Dl:Fc. The I578T substitution had little
effect on binding to Dl:Fc(Figure 3). Thus, the spl muta-
tion appears not to affect N function through a direct
effect on Dl binding, consistent with EGF repeat 14 not
being part of the known ligand binding site[9].
Direct interactions between the ligand-binding region and 
other regions of the N extracellular domain
EGF repeat 14 might be involved in binding to proteins
other than Dl. Other regions of the Notch extracellular
domain contains EGF repeats similar to Delta, and might
be candidates.
To test whether other EGF repeat regions from N might
interact with the ligand binding region, N1-10:Fc, N11-
20:Fc, N21-30:Fc and N31-36:Fc proteins were assessed
for interaction with N11-20 in vitro. N1-10:Fc, N11-20:Fc,
and N31-36:Fc proteins showed negligible specific bind-
ing to N11-20 (Figure 4A–B,D). By contrast, N21-30:Fc
showed saturable binding to N11-20 (Figure 4C).
Although the absolute levels of binding varied between
experiments, saturation binding to N11-20 was often
higher for N21-30:Fc than for Dl:Fc (Figure 4E).
If N21-30:Fc and Dl:Fc both interact with N11-20 through
the same binding site, then we would expect competition
for this common site. To test this, soluble Dl:V5His and
N21-30:V5His proteins were prepared and added as com-
petitors. Despite the fact that N21-30 and Dl proteins
were expected to be monomeric, but Fc-tagged proteins
are dimers[33], N21-30 competed for N21-30:Fc binding,
and Dl competed for Dl:Fc binding (Figure 5A,C). In addi-
tion, Dl competed for N21-30Fc binding (Figure 5B), and
N21-30 competed for Dl:Fc binding (Figure 5D). Thus,
purified Dl and N21-30 appeared to interact with N11-20
at the same or overlapping sites.
EGF repeat O-fucosylation and its contribution to 
Abruptex binding
We hypothesized that although the I578T mutation on
split did not affect interactions with Delta, it might affect
interactions with N21-30. In the intact N molecule, such
an effect could alter binding with Dl indirectly, if Dl com-
petes with N21-30 for access to the ligand binding
domain. Such a model could account for the suppression
of the spl mutation by Dlsup5.
The effect of the I578T mutation on interactions with
N21-30 and other Notch regions was assessed. Like N11-
20, the N11-14 and N11-14spl proteins were each bound
by N21-30:Fc, but not by N1-10:Fc, N11-20:Fc, or N31-
36:Fc (Figure 6A and data not shown). There was no dis-
cernible effect of the I578T substitution on the binding
(Figure 6B). Thus, N11-14 and N11-14spl each behaved
similarly to N11-20, without any discernible effect of the
altered fucosylation on binding interactions. Additional
experiments used artificial, four-EGF repeat proteins with
complementary patterns of predicted O-fucosylation sites
(see Materials and Methods). Such artificial proteins
bound equuivalently to Dl:Fc and N21-30:Fc, and their
complementary pattern of O-fucosylation sites did not
confer specific affinity for one another (data not shown).
Binding properties of the split mutant Figure 3
Binding properties of the split mutant. A. Dl:Fc showed saturable binding to adsorbed N11-14:V5:His protein, containing 
the ligand-binding site. B. Dl:Fc bound similarly to adsorbed N11-14spl:V5:His protein, containing an additonal site for o-fuco-
sylation.BMC Developmental Biology 2008, 8:4 http://www.biomedcentral.com/1471-213X/8/4
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Smaller proteins have been examined to begin to define
the specificity for Abruptex-region interactions. Figures 7A
and 7B show that EGF repeats 11–14 contain the binding
site for N21-30:Fc. EGF repeats 15–20 show little interac-
tion (data not shown). EGF repeats 11–20 and EGF
repeats 11–14 interacted quite poorly with both N21-
25:Fc and N26-30:Fc (Figures 7C–E). The overlapping
protein N22-27:Fc bound to EGF repeats 11–14 better,
consistent with the major binding site(s) lying within the
EGF repeats 22–27 region (Figure 7F).
Specific binding of N21-30:Fc to a Notch protein including EGF repeats 11–12 Figure 4
Specific binding of N21-30:Fc to a Notch protein including EGF repeats 11–12. A. N1-10:Fc did not bind to N11-20. 
B. N11-20:Fc did not bind to N11-20.C. N21-30:Fc showed saturable binding to N11-20. Although results vary from one pro-
tein batch to the next, in most cases more N21-30:Fc binds than does Dl:Fc (see panel E). D. N31-36:Fc did not show saturable 
binding to N11-20. E. Dl:Fc binding to N11-20.BMC Developmental Biology 2008, 8:4 http://www.biomedcentral.com/1471-213X/8/4
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pH dependence of interactions
In addition to the Dlsup5 mutation, other second-site sup-
pressors of split  map in the scabrous  and  gp150  genes,
which encode proteins found in late endosomes [35,36].
To better mimic the endosomal environment, the effect of
low pH on interactions of the ligand binding domain was
assessed. This required replacement of the Tris pH8.0
binding buffer. Either citric acid or Tris-maleate buffered
binding solutions gave similar results at pH 7.4 to those
described so far, and both these buffers were also usable
at pH 5.4 (Figure 8A,C). Binding of Dl;Fc to N11-20
increased markedly at pH 5.4, both in terms of maximum
binding, and apparent Kd (Figure 8B). No such increase
was seen with N21-30:Fc binding to N11-20, which might
be somewhat reduced (Figure 8D). To test whether O-fuc-
osylation pattern affected interactions at low pH, Dl:Fc
and N21-30:Fc binding was assessed with N11-14 and
N11-14spl at different pH's. N11-14spl always bound to
Dl:Fc or N21-30:Fc indistinguishably from N11-14,
whether binding was performed at pH 7.4 or pH 5.4 (Fig-
ure 9).
It has been suggested that ligands need recycling through
an endocytic compartment for activation [37-39]. Our
data raised the possibility that Dl might be activated by
acidity during recycling. If this was the case, then we
would expect that the 'activation' of DlFc observed at
pH5.4 would be irreversible, and maintained after return
to neutral pH. By contrast, if Dl:Fc interacts with N better
at low pH, this will be reversed at neutral pH. To distin-
Competition between Dl and the Abruptex region Figure 5
Competition between Dl and the Abruptex region. A. Binding of 10 ng (2.74 nM) N21-30:Fc to N11-20 is competed by 
increasing amounts of N21-30:V5:His. B. Binding of 10 ng (2.74 nM) N21-30Fc to N11-20 is competed by increasing amounts of 
Dl:V5:His. As Dl does not bind to N21-30 (see Figure 2D), Dl:V5:His binding to N11-20 is the likely mechanism. C. Binding of 
100 ng (23.2 nM) Dl:Fc to N11-20 is competed by increasing amounts of Dl:V5:His. D. Binding of 100 ng (23.2 nM) Dl:Fc to 
N11-20 is competed by increasing amounts of N21-30:V5:His. As Dl does not bind to N21-30 (see Figure 2D), Dl:V5:His bind-
ing to N11-20 is the likely mechanism.BMC Developmental Biology 2008, 8:4 http://www.biomedcentral.com/1471-213X/8/4
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guish these possibilities, Dl:Fc was pre-incubated at pH
5.4 for 1 h, then half the sample was assessed for binding
to N11-20 at pH 5.4, the other half neutralized and
assessed for binding to N11-20 at pH 7.4 (Figure 10).
Neutralized Dl:Fc bound to N11-20 less well than Dl:Fc at
pH5.4, and not distinguishable from Dl:Fc protein that
was never pre-incubated at pH 5.4 (Figure 10). The results
indicate that low pH did not activate Dl:Fc irreversibly,
but that pH made a direct, reversible contribution to the
binding interaction.
Discussion
In vitro studies were performed to explore how proteins
interact with the ligand binding region of Notch, with
Abruptex binding to the split mutant Figure 6
Abruptex binding to the split mutant. A. N21-30:Fc showed saturable binding to adsorbed N11-14:V5:His protein. B. 
N21-30:Fc bound similarly to adsorbed N11-14spl:V5:His protein.
Interactions between smaller proteins Figure 7
Interactions between smaller proteins. A. N21-30:Fc binding to adsorbed N11-20:V5:His protein. B. N21-30:Fc binding 
to adsorbed N11-4:V5:His protein. Saturation binding is increased compared to binding to adsorbed N11-20:V5:His protein 
(compare panel A), because 200 ng N11-14:V5:His protein is a greater molar amount than to 200 g N11-20:V5:His protein. C. 
N21-25:Fc shows reduced binding to N11-20:V5:His. D. N21-25:Fc shows reduced binding to N11-14:V5:His. E. N26-30:Fc 
shows little binding to N11-14:V5:His. F. N22-27:Fc shows saturable binding to N11-14:V5:His.BMC Developmental Biology 2008, 8:4 http://www.biomedcentral.com/1471-213X/8/4
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three main findings: 1) the EGF repeat 21–30 region of
Notch can compete with Dl for binding to the ligand
binding region of Notch; 2) Such interactions between
EGF repeat regions are not determined by O-fucosylation
pattern; 3) The interaction of Dl with N is significantly
enhanced at pH's typical of endosomes, more acidic than
has previously been used to assess Notch function.
The Abruptex domain competes with Delta binding
The EGF repeat 21–30 region of Notch bound to the
Notch ligand binding region in vitro, and competed with
the Dl extracellular domain for binding(Figures 5, 6). The
binding regions were mapped approximately to EGF
repeats 11–14 and EGF repeats 22–27, respectively (Fig-
ure 7). Other EGF repeat regions of Notch did not bind to
the ligand binding region in this assay (Figure 4).
Another recent study has suggested that the Abruptex
domain participates in Notch-Notch interactions, based
on indirect evidence[21]. The specific interactions pre-
dicted are not the same as that which we directly demon-
strate here. Our conclusions are conceptually similar,
however. It should be noted that our experiments might
not detect Notch-Notch interactions that required other
stabilizing interactions in the context of the entire Notch
molecule, or ternary complexes also involving Delta,
should such interactions exist.
O-fucosylation of the split mutant protein does not affect 
direct Notch-Delta binding
Historically, we sought to evaluate Notch-Notch interac-
tions because of the spl mutation of Notch, and its sup-
pression by the Dlsup5 mutation[26]. If the spl mutation
interfered with binding of Notch to the Abruptex domain
more than to Delta, this could account for increased
Notch activity, which could be suppressed by a further
mutation of Dl. We did not detect any effect of the spl
mutation on binding to Dl or to the EGF repeats 21–30
domain, however. Protein O-fucose is itself the substrate
of Fringe glycosyltransferases, so that EGF repeats can be
pH effects Figure 8
pH effects. A. Dl:Fc bound to adsorbed N11-20:V5:His protein at pH7.4. B. Dl:Fc binding to adsorbed N11-20:V5:His protein 
was significantly enhanced at pH5.4. Maximal binding was increased, 'Kd' was reduced. C. N21-30:Fc bound to adsorbed N11-
20:V5:His protein at pH7.4. D. N21-30:Fc bound similarly to adsorbed N11-20:V5:His protein at pH5.4. In this experiment, 
maximal binding was slightly reduced, and 'Kd' was slightly increased.BMC Developmental Biology 2008, 8:4 http://www.biomedcentral.com/1471-213X/8/4
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pH does not affect binding to the spl mutant Figure 9
pH does not affect binding to the spl mutant. A. Dl:Fc bound to adsorbed N11-14:V5:His protein at pH7.4, B. Dl:Fc 
bound similarly to adsorbed N11-14spl:V5:His protein at pH7.4, C. Dl:Fc binding to adsorbed N11-14:V5:His protein was 
enhanced at pH5.4, D. Dl:Fc binding to adsorbed N11-14spl:V5:His protein was similarly enhanced at pH5.4, E. N21-30:Fc 
bound to adsorbed N11-14:V5:His protein at pH7.4, F. N21-30:Fc bound similarly to adsorbed N11-14spl:V5:His protein at 
pH7.4, G. N21-30:Fc binding to adsorbed N11-14:V5:His protein was not enhanced at pH5.4, H. N21-30:Fc bound similarly to 
adsorbed N11-14spl:V5:His protein at pH5.4,BMC Developmental Biology 2008, 8:4 http://www.biomedcentral.com/1471-213X/8/4
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the carriers of a short oligosaccharide at this site[22].
Fringe modifies binding interactions and functions of
Notch and its ligands, although not all Notch functions
depend on Fringe [40,20,41-45]. It would be interesting
to investigate whether modification of O-fucose groups by
Fringe enzymes affects interactions between Notch
domains, but we did not investigate this because in vivo
the spl mutation affects Notch signaling independently of
Fringe [26]. Although it is possible that spl does not affect
protein-protein interactions of Notch, we cannot exclude
an effect on an interaction not studied here, perhaps
involving other proteins, should such interactions exist.
pH effects on Notch-Delta interactions
Low pH favored interaction of Dl with N(Figure 8). The
findings raise the possibility that Dl might displace
Abruptex-domain more effectively after endocytosis. A
role for endocytosis in Notch activation would be distinct
from the now well-established requirements for Epsin,
Neuralized, and Mind-bomb to endocytose Notch lig-
ands, both because these latter molecules act in the lig-
and-producing cell, and because they are hypothesized to
generate an active ligand recycled to the cell surface[46].
By contrast, we found the effect of pH on Dl to be revers-
ible, and therefore not likely to affect ligands after recy-
cling to the cell surface (Figure 10).
Although genetic evidence supports the idea that endocy-
tosis is required in the receptor-activated cell in addition
to the ligand-presenting cell[47], its specific role in Notch
signalling is uncertain. It is not certain whether ligand-
dependent Notch cleavage occurs inside the cell[8,48,49].
Dl is also believed to "cis-inactivate" Notch function
when co-expressed in the same cells [50-53]. Recent stud-
ies indicate that cis-inactivation occurs at the cell surface,
however, and that endocytosis is not required[54].
Possible roles of the Abruptex domain in vivo
Could the Abruptex domain interact with the ligand bind-
ing domain in intact Notch molecules in vivo, as in in
vitro experiments with protein fragments? Because muta-
tions within the Abruptex domain enhance Notch signal-
ing[13,25,29-32], it is reasonable to propose that the
Abruptex domain normally interferes with Notch activa-
tion. Competition between the Abruptex domain and
Delta for the ligand binding site of Notch provides a plau-
sible mechanism by which this could occur. It has also
been suggested that the Abruptex domain may be
involved in cis-inactivation [31,32]. The structural basis
for cis-inactivation is not known.
Notch activation is thought to require 'opening' of a
receptor structure that protects the juxtamembrane S2
cleavage site [11]. It is not known how ligand binding to
the EGFR11-12 region achieves this, because the S2 cleav-
age site is in the distant juxta-membrane region of the
Notch extracellular domain, separated by the Abruptex
domain and by other sequences (Figure 1). Ligand bind-
ing to the ligand-binding region could initiate a confor-
mational change by displacing the Abruptex domain[21].
It is not known how this would deprotect the S2 cleavage
site, however, especially as Notch molecules lacking EGF
repeats 1–18 are not active[55]. One alternative model is
that mechanical force unfolds the S2 region in response to
ligand binding [11,56]
EGF repeats 11–14 and 22–27 from the same molecule
seem unlikely to be in proximity if EGF repeats 10–21
form a stiff linear array, as is now thought[12]. Inter-
molecular Notch-Notch interactions might be possible,
however. Cell adhesion assays have not detected
homophilic interactions between Notch proteins [57],
but it is possible that Notch molecules on different cells
cannot interact, for example if inter-molecular interac-
tions have saturated before cells are mixed. In addition, Dl
binding to N in such assays requires sequences amino-ter-
Reversible pH effect Figure 10
Reversible pH effect. A. Dl:Fc bound to adsorbed N11-20:V5:His protein at pH7.4, after 1 hour pre-incubation at pH7.4. B. 
Dl:Fc binding to adsorbed N11-20:V5:His protein was enhanced at pH5.4, after 1 hour preincubation at pH5.4. C. Dl:Fc binding 
to adsorbed N11-20:V5:His protein at pH7.4 was unaffected by 1 hour preincubation at pH5.4.BMC Developmental Biology 2008, 8:4 http://www.biomedcentral.com/1471-213X/8/4
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minal to EGF repeats[58]. No such sequences are present
in the EGFR21-30 segment of Notch, which was not able
to replace the extracellular domain of Dl in cell adhesion
and Notch signalling assays (our unpublished results).
Should they occur, inter-molecular Notch-Notch interac-
tions could cluster Notch molecules into dimers or into
chains. It will be interesting to determine whether such
structures occur and contribute to Notch regulation.
Conclusion
We demonstrate binding in vitro between the Abruptex
domain of the Notch extracellular domain and its ligand-
binding domain, and propose that a similar interaction in
vivo creates a barrier to Notch activation that is overcome
by ligand binding,
Methods
Cloning
Plasmids expressing regions of the Notch or Delta extra-
cellular domains were fused to a human IgG Fc fragment
using a PCR strategy to clone open reading frames into an
expression vector, pMT-Fc, that incorporates the amino-
terminal signal sequence from the BiP protein. First,
intronic sequences were removed from the Fc coding
region. Two Fc exons were amplified from the pSecTag
plasmid (Invitrogen) using two primer pairs: ccgtctgaga-
catgcccaccgtgccca/gaaggcctttggctttggagatggttttc and gctgcg-
cagccccgcgcaccaca/gctctagatttacccggagacagggagag. PCR
products were digested by XhoI/StuI and FspI/XbaI
respectively, then inserted into XhoI XbaI digested pMT/
BiP/V5-His (Invitrogen) in a three-way ligation. Extracel-
lular portions of Notch or Delta were expressed by ampli-
fication from the pMTN or pMTDL plasmid templates.
PCR products were digested with EcoRI and XhoI and
ligated with EcoRI and XhoI digested pMT-Fc. The primers
for Notch were:
ggaattcgttggtggccgcttcctgcacaag – forward primer from
Leu57 N-terminal to EGF repeat 1.
ggaattcgtcagaggacatagatgaatgcgat – forward primer from
Ser447 N-terminal to EGF repeat 11.
ggaattcggagatcaatatcaacgattgc – forward primer from
Glu600 N-terminal to EGF repeat 15.
ggaattcggaaacgaatattgacgactgt – forward primer from
Glu827 N-terminal to EGF repeat 21.
ggaattcgcagacaaacgatgaggattg – forward primer from
Gln1000 N-terminal to EGF repeat 26.
ggaattcggaactgaacatcgatgactgtg – forward primer from
Glu1219 N-terminal to EGF repeat 31.
ccgctcgagttcatctatgtcctcgaacaatcc – reverse primer to
Glu452 C-terminal to EGF repeat 10.
ccgctcgagatcgttgatattgatctcgcaac – reverse primer to
Asp605 C-terminal to EGF repeat 14.
ccgctcgaggtcgtcaatattcgtttcgcac – reverse primer to Asp832
C-terminal to EGF repeat 20.
ccgctcgagatcctcatcgtttgtctgacaattg – reverse primer to
Asp1025 C-terminal to EGF repeat 25.
ccgctcgaggtcatcgatgttcagttcgcaattg – reverse primer to
Asp1224 C-terminal to EGF repeat 30.
ccgctcgaggttggcatcatagatatcgcag – reverse primer to
Asp1456 C-terminal to EGF repeat 36.
The primers for Delta were:
ggaattcgcaggttcacagttcacagttccggcagc – forward primer
from Gln19.
ccgctcgagctcatcgcactgcttgcccc – reverse primer to Glu560.
Plasmids expressing regions of the Notch or Delta extra-
cellular domains tagged with V5-6His were constructed by
ligating pMT/BiP/V5-His instead of pMT-Fc.
To replace Ile464 with Thr in EGF repeat 11 from Notch,
the oligonucleotide ggcctACCtgcgtgaacacaccgggcag was
used for oligonucleotide-mediatedmutagenesis. To
replace Ser502 with Ile in EGF repeat 12 from Notch, the
oligonucleotide cgggATCtgcctggatgatccggggaacg was used
for oligonucleotide-mediatedmutagenesis. To generate
fucosylated or un-fucosylated 4-EGF repeat proteins, EGF
repeats 11–12 containing either a Thr464 mutations to
introduce a fucosylation site to EGF repeat 11, or a Ile502
mutation of the fucosylation site on EGF repeat 12, were
amplified and each cloned as tandem repeats. In the first
reaction the forward primer (from Ser447) was gaagatct-
tcagaggacatagatgaatg, the reverse primer (to Asp526) was
ccatcgatttcgcactgtgtgcccgtg. In the second reaction the for-
ward primer (from Asp449) was ccatcgatatagatgaatgcgat-
caggagtc, the reverse primer (to Glu529)
wasccgctcgagttcgtccaatgtcgatttcgcac. The two PCR prod-
ucts were digested with BglII/ClaI and ClaI/XhoI respec-
tively and subcloned into BglII/XhoI disgested pMT/BiP/
V5 using a three-way ligation.
Cell culture
Schneider cells were kept at 25°C in Shields and Sang M3
medium (Sigma) supplemented with 10% heat-inacti-
vated fetal bovine serum (Sigma) and 50 U/ml penicillin,
50 U/ml streptomycin (Invitrogen). Cells were transfectedBMC Developmental Biology 2008, 8:4 http://www.biomedcentral.com/1471-213X/8/4
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using lipofectin as described [59]. Proteins were harvested
from serum-free M3 medium 48 h after induction with
0.5 mM CuSO4. Secreted His-tagged proteins were puri-
fied from conditioned media using ProbondTM resin
(Invitrogen), eluted in 50 mM NaH2PO4, 500 mM NaCl,
300 mM imidazole, pH7.5 and stored at -80°C prior to
serial dilution in TBS or other buffers as described for
use(TBS: 10 mM Tris-Cl pH 8.0 150 mM NaCl, 1 mM
CaCl). Fc-Tagged proteins were purified using Protein A
beads (Amersham), eluted with 0.1 M Glycine HCl pH 2.6
into 10 mM Tris pH 7.4 and stored at -80°C prior to serial
dilution in TBS or other buffers as described for use. Purity
and yield were assessed using a Protein-Assay Kit from
Pierce and Coomassie Blue staining of SDS-PA gels. Fc-
tagged proteins were usually recovered ~95% pure, His-
tagged proteins ~85–90% pure. Storage for more than a
few weeks reduced activity in binding assays, although no
degradation was apparent.
Binding Assay
200 ng of His-tagged protein eg N11-20V5H was added to
each well of a 96-well plate (Apogent) in 50 μL TBS at 4°C
overnight. After 3 TBS washes, the plate was blocked with
10 mM Tris-Cl (pH 8.0), 150 mM NaCl, 1 mM CaCl2, 3%
BSA at 4°C overnight. After 3 washes with TBS containing
0.05% Tween20, known amounts of purified Fc fusion
protein (eg Dl:Fc) were added in 50 microlitres of TBS,
and after 2 h incubation the plate was washed 3x with TBS
+ 0.05% Tween20. After incubation with HRP-conjugated
anti-human IgG antibody (1:5000 in TBS), the plate was
washed three more times in TBS + 0.05% Tween20, and
bound antibody detected with the HRP development rea-
gent and quantified with a microplate reader (Perkin
Elmer Wallac Victor2). Other pH values were achieved
using citric acid/Na2HPO4 or Tris maleate/NaOH buffers
in place of Tris pH8.0[60]. Tris maleate/NaOH appeared
to show better Ca solubility.
Binding curves
Data were compiled using Prizm 4 software (GraphPad).
Errors (standard deviations from replicate experiments)
are shown for all datapoints (but are too small to see in
some figures). Molarities bound are expressed on a mon-
omer basis.
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